US Patent 7083785 Methods of treatment by administering an anti-BCMA antibody

Is a

Patent

Patent attributes

Current Assignee

Biogen

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

70837850

Patent Inventor Names

Pascal Schneider0

Christine Ambrose0

Fabienne MacKay0

Jeffrey Browning0

Jeffrey Thompson0

Jurg Tschopp0

Date of Patent

August 1, 2006

Patent Application Number

100774380

Date Filed

February 15, 2002

Patent Citations Received

‌

US Patent 11952428 BCMA chimeric antigen receptors and uses thereof

‌

US Patent 12016923 Claudin 18.2 T cell-antigen couplers and uses thereof

‌

US Patent 11965025 Method of treating solid cancers with bispecific interleukin-anti-TCRß molecules

‌

US Patent 11970545 T cell-antigen coupler with Y182T mutation and methods of uses thereof

‌

US Patent 11851497 CD137 antibodies and tumor antigen-targeting antibodies and uses thereof

‌

US Patent 11878035 T cell-antigen coupler with various construct optimizations

‌

US Patent 11912776 Chimeric antigen receptors targeting B-cell maturation antigen

‌

US Patent 11939389 BCMA chimeric antigen receptors and uses thereof

Patent Primary Examiner

‌

Elizabeth Kemmerer

Patent abstract

A novel receptor in the TNF family is provided: BAFF-R. Chimeric molecules and antibodies to BAFF-R and methods of use thereof are also provided.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

US Patent 7083785 Methods of treatment by administering an anti-BCMA antibody

Contents

Patent attributes

Timeline

Further Resources

References

Find more entities like US Patent 7083785 Methods of treatment by administering an anti-BCMA antibody